DR. MOHAMEDAZHAR GANGAT M.D.
Prescription History 1295099208
Internal Medicine - Infectious Disease in Bangor, ME
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. MOHAMEDAZHAR GANGAT M.D., an active Infectious Disease specialist practicing in Bangor, ME. Our medical registry currently tracks 13 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 339 documented patient claims. Among these therapy options, the most frequently utilized medication is Descovy, which accounts for 86 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other ME PrescribersVs. ME Avg |
|---|---|---|---|
| DescovyEmtricitabine/Tenofov Alafenam | 86 | $2,248.99▼ below ME avg | ▲ More than typical |
About Descovy: This product is used with other HIV medications to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. This product is a combination of two different drugs: emtricitabine and tenofovir alafenamide. Emtricitabine is called a nucleoside reverse transcriptase inhibitor, while tenofovir alafenamide is called a nucleotide reverse transcriptase inhibitor. They are often called NRTIs. This product should not be used by itself to help control HIV infection. Doing so can make your treatment less effective. Use combination treatment with at least one other HIV medication. This product is also approved in the US to help prevent HIV infection in people who have a high risk for infection. Some things that increase risk include having a partner infected with HIV, having unprotected sex, having multiple sex partners, infection with a sexually transmitted disease-STD, or use/abuse of drugs or alcohol. Emtricitabine/tenofovir alafenamide is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. In 2024, this provider wrote 86 Medicare prescriptions for Descovy, about 2.3 times the volume of the typical Maine prescriber of this medication (37.3). Medicare paid an average of $2,248.99 per fill, versus $2,259.07 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the ME average for this medication. 90 30-Day Fills standardized to 30-day supplies 2,700 Days of Medication total across all patients in 2024 | |||
| Cefazolin Sodium | 36 | $34.17▼ below ME avg | ▲ More than typical |
About Cefazolin Sodium: Cefazolin is an antibiotic used to treat a wide variety of bacterial infections. Show more ▾ It may also be used before and during certain surgeries to help prevent infection. This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. A semisynthetic cephalosporin analog with broad-spectrum antibiotic action due to inhibition of bacterial cell wall synthesis. It attains high serum levels and is excreted quickly via the urine. In 2024, this provider wrote 36 Medicare prescriptions for Cefazolin Sodium, about 1.9 times the volume of the typical Maine prescriber of this medication (19.3). Medicare paid an average of $34.17 per fill, versus $44.28 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the ME average for this medication. 36 30-Day Fills standardized to 30-day supplies 204 Days of Medication total across all patients in 2024 | |||
| TivicayDolutegravir Sodium | 35 | $2,284.74▼ below ME avg | ▼ Less than typical |
About Tivicay: Dolutegravir is used with other HIV medications to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Dolutegravir belongs to a class of drugs known as integrase inhibitors. It blocks the virus from growing and infecting more cells. Dolutegravir is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. An HIV integrase inhibitor that is used in the treatment of HIV INFECTIONS in combination with other ANTI-HIV AGENTS. In 2024, this provider wrote 35 Medicare prescriptions for Tivicay, about 74% of the volume of the typical Maine prescriber of this medication (47.2). Medicare paid an average of $2,284.74 per fill, versus $2,379.60 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the ME average for this medication. 35 30-Day Fills standardized to 30-day supplies 1,050 Days of Medication total across all patients in 2024 | |||
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 30 | $4,002.09▼ below ME avg | ▼ Less than typical |
About Biktarvy: This combination product is used by itself to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. This product is a combination of 3 different drugs: bictegravir, emtricitabine, and tenofovir alafenamide. Bictegravir is called an integrase strand transfer inhibitor-INSTI. Emtricitabine is called a nucleoside reverse transcriptase inhibitor, while tenofovir alafenamide is called a nucleotide reverse transcriptase inhibitor. Emtricitabine and tenofovir alafenamide are often called NRTIs. Bictegravir/emtricitabine/tenofovir alafenamide is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. In 2024, this provider wrote 30 Medicare prescriptions for Biktarvy, about half the volume of the typical Maine prescriber of this medication (61.5). Medicare paid an average of $4,002.09 per fill, versus $4,083.65 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the ME average for this medication. 30 30-Day Fills standardized to 30-day supplies 900 Days of Medication total across all patients in 2024 | |||
| CeftriaxoneCeftriaxone Sodium | 28 | $31.07▼ below ME avg | ≈ Typical |
About Ceftriaxone: Ceftriaxone is used to treat a wide variety of bacterial infections. Show more ▾ This medication belongs to a class of drugs known as cephalosporin antibiotics. It works by stopping the growth of bacteria. This drug is not recommended for use in newborns with high blood bilirubin levels and premature infants due to increased risk of side effects. Ask the doctor or pharmacist for details. A broad-spectrum cephalosporin antibiotic and cefotaxime derivative with a very long half-life and high penetrability to meninges, eyes and inner ears. In 2024, this provider wrote 28 Medicare prescriptions for Ceftriaxone, about 1.2 times the volume of the typical Maine prescriber of this medication (23.1). Medicare paid an average of $31.07 per fill, versus $35.34 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the ME average for this medication. 28 30-Day Fills standardized to 30-day supplies 201 Days of Medication total across all patients in 2024 | |||
| Doxycycline Hyclate | 27 | $37.16 | ≈ Typical |
About Doxycycline Hyclate: This medication is used to treat a wide variety of bacterial infections, including those that cause acne. Show more ▾ This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A synthetic tetracycline derivative with similar antimicrobial activity. In 2024, this provider wrote 27 Medicare prescriptions for Doxycycline Hyclate, about the same volume as the typical Maine prescriber of this medication (24.7). Medicare paid an average of $37.16 per fill, versus $12.94 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 55 30-Day Fills standardized to 30-day supplies 1,532 Days of Medication total across all patients in 2024 | |||
| Vancomycin Hcl | 24 | $128.79 | ▲ More than typical |
About Vancomycin Hcl: Vancomycin is used to treat a certain intestinal condition (colitis) that may rarely happen after treatment with antibiotics. Show more ▾ This condition causes diarrhea and stomach/abdominal discomfort or pain. When vancomycin is taken by mouth, it stays in the intestines to stop the growth of bacteria that cause these symptoms. This antibiotic treats only bacterial infection in the intestines. It will not work for bacterial infections in any other part of the body or for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear. In 2024, this provider wrote 24 Medicare prescriptions for Vancomycin Hcl, about 1.3 times the volume of the typical Maine prescriber of this medication (19.1). Medicare paid an average of $128.79 per fill, versus $106.11 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 24 30-Day Fills standardized to 30-day supplies 170 Days of Medication total across all patients in 2024 | |||
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $5.01▼ below ME avg | ▼ Less than typical |
About Amoxicillin-Clavulanate Potass: Amoxicillin/clavulanic acid is a combination penicillin-type antibiotic used to treat a wide variety of bacterial infections. Show more ▾ It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. In 2024, this provider wrote 14 Medicare prescriptions for Amoxicillin-Clavulanate Potass, about 63% of the volume of the typical Maine prescriber of this medication (22.2). Medicare paid an average of $5.01 per fill, versus $10.10 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the ME average for this medication. 14 30-Day Fills standardized to 30-day supplies 156 Days of Medication total across all patients in 2024 | |||
| Cephalexin | 14 | $11.67 | ▼ Less than typical |
About Cephalexin: This medication is used to treat a wide variety of bacterial infections. Show more ▾ This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms. In 2024, this provider wrote 14 Medicare prescriptions for Cephalexin, about half the volume of the typical Maine prescriber of this medication (24). Medicare paid an average of $11.67 per fill, versus $8.17 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 22 30-Day Fills standardized to 30-day supplies 557 Days of Medication total across all patients in 2024 | |||
| AvycazCeftazidime/Avibactam | 12 | $415.19 | – No State Data |
About Avycaz: This medication is used to treat a wide variety of bacterial infections. Show more ▾ This product contains 2 different medications: ceftazidime and avibactam. Ceftazidime is a cephalosporin antibiotic that works by stopping the growth of bacteria. Avibactam is an enzyme inhibitor (beta-lactamase inhibitor) that helps ceftazidime work better. In 2024, this provider wrote 12 Medicare prescriptions for Avycaz. Medicare paid an average of $415.19 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $415.19 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 14 Days of Medication total across all patients in 2024 | |||
| Azithromycin | 11 | $29.79 | ▼ Less than typical |
About Azithromycin: Azithromycin is used to treat a wide variety of bacterial infections. Show more ▾ It is a macrolide-type antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis. In 2024, this provider wrote 11 Medicare prescriptions for Azithromycin, about half the volume of the typical Maine prescriber of this medication (24.8). Medicare paid an average of $29.79 per fill, versus $6.23 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 305 Days of Medication total across all patients in 2024 | |||
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 11 | $3,681.03▼ below ME avg | ≈ Typical |
About Genvoya: This product is used to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. This product contains 4 different medications: elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide. Elvitegravir is known as an integrase inhibitor. Cobicistat helps elvitegravir work better. Emtricitabine is called a nucleoside reverse transcriptase inhibitor, while tenofovir alafenamide is called a nucleotide reverse transcriptase inhibitor; both kinds of drugs are often called NRTIs. Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. A pharmaceutical preparation of the ANTI-HIV AGENTS elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate that is used in the treatment of HIV INFECTIONS. In 2024, this provider wrote 11 Medicare prescriptions for Genvoya, about 78% of the volume of the typical Maine prescriber of this medication (14.1). Medicare paid an average of $3,681.03 per fill, versus $4,137.40 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average ME prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the ME average for this medication. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2024 | |||
| PrezistaDarunavir | 11 | $1,990.15 | – No State Data |
About Prezista: This drug is used with other HIV medications to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Darunavir belongs to a class of drugs known as protease inhibitors. Darunavir must be given with certain other medications (such as cobicistat, ritonavir) to increase ("boost") the levels of darunavir. This helps darunavir work better. Darunavir is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. This medication is not recommended for use in children younger than 3 years due to the increased risk of serious side effects. An HIV PROTEASE INHIBITOR that is used in the treatment of AIDS and HIV INFECTIONS. Due to the emergence of ANTIVIRAL DRUG RESISTANCE when used alone, it is administered in combination with other ANTI-HIV AGENTS. In 2024, this provider wrote 11 Medicare prescriptions for Prezista. Medicare paid an average of $1,990.15 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $1,990.15 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for DR. MOHAMEDAZHAR GANGAT M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Infectious Disease prescribing approach at this Bangor, ME practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among ME prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
